Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun 29;10(3):e2020074.
doi: 10.5826/dpc.1003a74. eCollection 2020 Jul.

Prevention and Treatment of Chemotherapy-Induced Alopecia

Alfredo Rossi  1 , Gemma Caro  1 , Maria Caterina Fortuna  1 , Flavia Pigliacelli  1 , Andrea D'Arino  1 , Marta Carlesimo  1
Affiliations
Review

Prevention and Treatment of Chemotherapy-Induced Alopecia

Alfredo Rossi et al. Dermatol Pract Concept. .

Abstract

Background: Chemotherapy-induced alopecia (CIA) is one of the most dramatic side effects of chemotherapy. Currently no guidelines are available for its prevention and treatment. Several devices and drugs are used, but results are often disappointing.

Aims: Our aim is to analyze drugs and devices proposed in the literature for prevention and treatment of CIA induced by cytotoxic drugs and to discuss the evidenced-based opinion.

Methods and results: Scalp cooling is the only agent that has been approved by the US Food and Drug Administration for CIA prevention. Minoxidil and bimatoprost should not be used during chemotherapy administration, but they can be used after chemotherapy discontinuation to obtain greater regrowth.

Conclusions: Therapy should always be modulated for the patient and no fixed protocol should be used. Trichoscopy and trichogram could be useful tools in supporting this treatment.

Keywords: alopecia; chemotherapy; hair loss; treatment.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors have no conflicts of interest to disclose.

References

    1. Balagula Y, Rosen ST, Lacouture ME. The emergence of supportive oncodermatology: the study of dermatologic adverse events to cancer therapies. J Am Acad Dermatol. 2011;65(3):624–635. doi: 10.1016/j.jaad.2010.06.051. - DOI - PubMed
    1. Trüeb RM. Chemotherapy-induced hair loss. Skin Ther Lett. 2010;15(7):5–7. - PubMed
    1. Rubio-Gonzalez B, Juhász M, Fortman J, Mesinkovska NA. Pathogenesis and treatment options for chemotherapy-induced alopecia: a systematic review. Int J Dermatol. 2018;57(12):1417–1424. doi: 10.1111/ijd.13906. - DOI - PubMed
    1. Paus R, Haslam IS, Sharov AA, Botchkarev VA. Pathobiology of chemotherapy-induced hair loss. Lancet Oncol. 2013;14(2):e50–e59. doi: 10.1016/S1470-2045(12)70553-3. - DOI - PubMed
    1. Miteva M, Misciali C, Fanti PA, Vincenzi C, Romanelli P, Tosti A. Permanent alopecia after systemic chemotherapy: a clinicopathological study of 10 cases. Am J Dermatopathol. 2011;33(4):345–350. doi: 10.1097/DAD.0b013e3181fcfc25. - DOI - PubMed

LinkOut - more resources